Related Experiment Video
Updated: Mar 22, 2026
07:50
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
2.5K
Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular Activity
Damien Veau1,2, Serhii Krykun1, Giorgia Mori3
1Laboratoire de Synthèse et Physicochimie de Molécules d'Intérêt Biologique (SPCMIB), CNRS-UMR5068, Université Paul Sabatier-Toulouse III, 118 Route de Narbonne, 31062, Toulouse Cedex 9, France.
Chemmedchem
|April 22, 2016
Summary
New triazolophthalazine compounds show potent activity against tuberculosis (TB), including multidrug-resistant strains. These novel agents offer a promising alternative for developing new TB treatments.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Microbiology
Background:
- Tuberculosis (TB) is a leading global cause of mortality.
- The rise of multidrug-resistant TB (MDR-TB) necessitates novel therapeutic strategies.
- Existing treatments face challenges due to resistance and toxicity.
Purpose of the Study:
- To explore novel 3-substituted triazolophthalazines as potential anti-TB agents.
- To evaluate the antimycobacterial activity and cytotoxicity of synthesized compounds.
- To identify new therapeutic leads for combating drug-susceptible and drug-resistant TB.
Main Methods:
- Synthesis of novel 3-substituted triazolophthalazines from hydralazine hydrochloride.
- Antimycobacterial activity testing against Mycobacterium tuberculosis (M.tb) H37 Rv strain.
- Cytotoxicity evaluation using HCT116 human cell lines.
- Activity assessment against various multidrug-resistant M.tb strains.
Main Results:
- Four synthesized compounds exhibited potent antimycobacterial activity (MIC <10 μg/mL).
- No observed cytotoxicity against HCT116 cells (IC50 >100 μm).
- The most potent compounds demonstrated significant activity against multidrug-resistant M.tb strains.
Conclusions:
- 3-substituted triazolophthalazines are easily synthesized and possess significant antimycobacterial properties.
- These compounds show promise as novel therapeutic leads for TB, including MDR-TB.
- The distinct mode of action suggests potential to overcome existing resistance mechanisms.
More Related Videos
Related Concept Videos
01:28Pulmonary Tuberculosis V
750
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
750
01:15Anthelminthic Agents
33
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
33
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
2.3K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
2.3K
01:31Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
01:15Drugs that Stabilize Microtubules
2.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
01:26Pulmonary Tuberculosis IV
626
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
626